Back to MW Marshall Wace, LLP

BHVNBHVN

Showing 8 of 16 quarters

Position history for MWMarshall Wace, LLP's holdings in Biohaven Ltd.

Yes. Marshall Wace holds 651,349 shares of BHVN (Biohaven), worth $9.7M, as of its Q2 2026 13F filing. It increased the position by 298,744 shares (+84.7%) from Q1 2026. Marshall Wace has held BHVN since Q4 2025, across 3 quarterly 13F filings.

Current Value

$9.7M

Current Shares

651,349

Total Value Change

-$8.9M

Total Shares Change

+279,680

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
651,349
+84.7%
$9.7M0.0%$14.88
43
2026-Q1
Increased
352,605
+1074.3%
$3M0.0%$8.46
43
2025-Q4
New
30,027
—
$339,0050.0%$11.29
33
2025-Q3
Exited
0
-100.0%
$00.0%$15.01
0
2025-Q2
Decreased
26,379
-88.7%
$372,2080.0%$14.11
0
2025-Q1
Decreased
234,047
-36.2%
$5.6M0.0%$24.04
0
2024-Q4
Decreased
366,891
-1.3%
$13.7M0.0%$37.35
0
2024-Q3
Increased
371,669
+252.1%
$18.6M0.0%$51.00
46

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used